首页>
外国专利>
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME AND CRTH2
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME AND CRTH2
展开▼
机译:体位性静坐性鞭毛综合征和CRTH2
展开▼
页面导航
摘要
著录项
相似文献
摘要
T cell surface marker, CRTH2, is a target for treating Postural Orthostatic Tachycardia Syndrome, a hemodynamic abnormality. Targeting CRTH2 permits control of disease symptoms in POTS, for which no FDA approved treatment is currently available. Cell surface expression on certain T cell subsets characterizes the syndrome. Cell surface expression can be conveniently determined in plasma samples using flow cytometry.
展开▼